期刊文献+

拓扑替康诱导肺癌细胞HTB-56凋亡早期线粒体膜电位的变化

Mitochondrial membrane potential change in topotecan inducing apoptosis of lung cancer cells HTB-56
原文传递
导出
摘要 目的探讨拓扑替康诱导肺癌细胞HTB-56凋亡早期线粒体膜电位的改变。方法选择人肺癌细胞HTB-56细胞株,JC-1荧光染色标记线粒体,用早期流式细胞仪检测拓扑替康作用于HTB-56细胞不同时间细胞线粒体膜电位。采用琼脂糖凝胶电泳检测拓扑替康作用不同时间引起HTB-56细胞凋亡情况。结果经拓扑替康处理后48 h、72 h HTB-56细胞出现了明显的凋亡带,对照组未见明显亮带影。4 h后细胞线粒体膜电位下降,8 h后细胞膜电位明显下降,且下降程度随时间延长而增大。且药物组绿/红荧光比值与对照组比较均有显著性差异(P<0.05)。结论拓扑替康诱导肺癌细胞HTB-56可使之凋亡,其机制可能与线粒体膜电位在凋亡极早期发生改变有关。 Objective To investigate the mitochondrial membrane potential changes in topotecan inducing apoptosis in lung cancer cells HTB-56. Methods Mitochondrial of lung cancer cells HTB-56 was labeled by JC-1 fluorescence dye, mitocbondrial membrane potential was detected using flow cytometry after topotecan inducing apoptosis of lung cancer cells HTB-56 at different times, topotecan inducing apoptosis of lung cancer cells HTB-56 at different times was detected by agarose gel electrophoresis. Results The HTB-56 cells treated by topotecan revealed a obvious bright band in 48 hours and 72 hours, mitochondrial membrane potential decreased in 4 hours or more in 8 hours, and decreased over time. Green/red fluorescence ratio has a significant difference between drug group and control group ( P 〈 0. 05 ). Conclusion Topotecan can induce apoptosis of lung cancer cells HTB-56 , the mechanism of apoptosis can be related to mitochondrial membrane potential changes in very early in apoptosis.
出处 《中华肺部疾病杂志(电子版)》 CAS 2013年第1期36-37,44,共3页 Chinese Journal of Lung Diseases(Electronic Edition)
基金 2009年大连市科技局科技计划项目(项目编号:2009E11SF231) 2009年大连大学附属中山医院院长基金项目
关键词 支气管肺癌 拓扑替康 细胞凋亡 线粒体 膜电位 Bronchogenic carcinoma Topoteean Cells apoptosis Mitochondrial, membrane potential
  • 相关文献

参考文献9

  • 1Horn L,Sandler AB. Emerging date with antiangiogenictherapies in early and advanced non-small cell lung cancer[J].Clinical Lung Cancer,2009,(01):S7-S16.
  • 2Jemal A,Siegel R,Xu J. Cancer statistics,2010[J].CA:A Cancer Journal for Clinicians,2010,(05):277-300.
  • 3Schiller JH,Harrington D,Belani CP. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J].New England Journal of Medicine,2002,(02):92-98.
  • 4高文斌,郑真真,高丰,韩传军,黄建辉,张晓晨,王武龙,汪艾曼,王若雨,方今女.低剂量拓扑替康诱导肺癌脑转移HTB-56/DDP细胞株凋亡机制的研究[J].中华肺部疾病杂志(电子版),2012,5(5):36-39. 被引量:2
  • 5高文斌,马建增,郑真真,黄剑辉,王刚,吕金燕,王若雨,曹阳,方今女.拓扑异构酶Ⅰ抑制剂对小鼠Lewis肺癌细胞杀伤和诱导凋亡作用的研究[J].中国实用医刊,2011,38(12):54-55. 被引量:1
  • 6Staker BL,Hjerrild K,Feese MD. The mechanism of topoisomeraseI poisoning by a camptothecin analog[J].Proceedings of the National Academy of Sciences(USA),2002,(24):15387-15392.
  • 7Facompre M,Carrasco C,Colson P. DNA binding and topoisomeraseI poisoning activities of novel disaccharide indolocarbazoles[J].Molecular Pharmacology,2002,(05):1215-1227.
  • 8Green DR,Reed JC. Mitochondria and apoptosis[J].Science,1998,(5381):1309-1312.
  • 9Glaser T,Weller M. Caspase-dependent chemotherapy induced deathof glioma cells requires mitochondrial cytochrome C release[J].Biochemical and Biophysical Research Communications,2001,(02):322-327.

二级参考文献22

  • 1Parkin DM,Bray F,Ferlay J. Global cancer statistics,2002.CA Cancer[J].Clin,2005.74-108.
  • 2Meyers CA,Smith JA,Bezjak A. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium:results of a randomized phase Ⅲ trial[J].Clinical Oncology,2004.157-165.
  • 3Langer CJ,Mehta MP. Current management of brain metastases,with a focus on systemic options[J].Clinical Oncology,2005.6207-6219.
  • 4Kawabe T,Phi JH,Yamamoto M. Treatment of brain metastasis from lung cancer[J].Progress in Neurological Surgery,2012.148-155.
  • 5Pommier Y. Topoisomerase Ⅰinhibitors:camptothecins and beyond[J].Nature Reviews Cancer,2006,(10):789-802.
  • 6Blaney SM,Cole DE,Balis FM. Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates[J].Cancer Research,1993,(04):725-727.
  • 7Sung C,Blaney SM,Cole DE. A pharmacokinetic model of topotecan clearance from plasma and cerebrospinal fluid[J].Cancer Research,1994,(19):5118-5122.
  • 8Landonio G,Sartore-Bianchi A,Giannetta L. Controversies in the management of brain metastases:the role of chemotherapy[J].Forum(Genova),2001,(01):59-74.
  • 9van den Bent MJ. The role of chemotherapy in brain metastases[J].European Journal of Cancer,2003,(15):2114-2120.
  • 10Bernardo G,Cuzzoni Q,S trada MR. First-line chemotherapy with vinorelbine,gemcitabine,and carboplatin in the trearment of brain metastases from non-small-cell lung cancer:a phaseⅡstudy[J].Cancer Investigation,2002,(03):293-302.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部